Advances in medicine have significantly prolonged the life expectancy of people, however, there is a growing challenge to control infectious diseases associated with health care. In order to manage this problem in a timely and comprehensive manner, surveillance is required to first detect and then perform interventions to prevent the spread of infections. The clinical microbiology laboratory has an important role in providing information to isolate patients and provide appropriate antimicrobial treatment. Based on the regulation of initially detecting and isolating patients coming from other hospital centers and those hospitalized in Critical Patient Units and other services, the incorporation of molecular surveillance of resistance mechanisms is a tool that has made it possible to speed up this process and to learn about these mechanisms in order to reduce their transmission within the hospital. The implementation includes the diagnosis of Covid-19 and other viruses of medical importance.
The objectives of this presentation are to present the experience in the use of molecular surveillance in monitoring at admission and its importance in reducing transmission within the hospital and the rational use of antimicrobials and the impact of the implementation of the diagnosis of Covid and other viruses of epidemiological importance.